USAC:NYSEUSA Compression Partners, LP Analysis
Data as of 2026-09-20 - not real-time
$26.87
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
USA Compression Partners, LP is priced at $26.87 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 3.0%. With RSI at 50.6 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at $26.00 and resistance at $27.93.
The shares look overvalued, trading on 25.1 times earnings above a sector average of 17.8. Consensus targets land 11.6% above where the shares trade now. Revenue is growing at 36.8% on a 12.4% profit margin. The 7.82% dividend yield looks stretched against payout coverage.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 21.3%, a beta of 0.15 and a maximum drawdown of 18.1%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 2/10 conviction over the longer horizon.
The shares look overvalued, trading on 25.1 times earnings above a sector average of 17.8. Consensus targets land 11.6% above where the shares trade now. Revenue is growing at 36.8% on a 12.4% profit margin. The 7.82% dividend yield looks stretched against payout coverage.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 21.3%, a beta of 0.15 and a maximum drawdown of 18.1%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 2/10 conviction over the longer horizon.
Top Market Events
Strong quarterly results driven by strategic acquisition, with 50% of 2027 new units already contracted amid robust...DALLAS, September 10, 2026--USA Compression Partners, LP NYSE: USAC the "Partnership" today announced the pricing of a...Why USA Compression Partners is back on investor radars USA Compression Partners USAC has drawn fresh attention after...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 26.56
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 25.1 versus sector average of 17.8
- Dividend yield of 7.82% looks stretched against payout coverage
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 25.1 versus sector average of 17.8
- Dividend yield of 7.82% looks stretched against payout coverage
- Analyst targets imply +11.6% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth36.80%
Profit Margin12.43%
P/E Ratio25.1
ROE122.35%
ROA7.15%
Debt/Equity1030.25
P/B Ratio13.6
Op. Cash Flow$447.2M
Free Cash Flow$284.3M
Industry P/E17.8
Technical Analysis
TrendBullish
RSI50.6
Support$26.00
Resistance$27.93
MA 20$26.99
MA 50$26.61
MA 200$26.56
MACDBearish
VolumeIncreasing
Fear & Greed Index94.98
Valuation
Fair Value$45.67
Target Price$30.00
Upside/Downside11.65%
GradeOvervalued
TypeBlend
Dividend Yield7.82%
Risk Assessment
Beta0.15
Volatility21.34%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.